NDC 33342-051 – Losartan potassium and Hydrochlorothiazide
Losartan Potassium 100 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet, Film Coated · Oral
Product NDC33342-051
Product details
- Brand name
- Losartan potassium and Hydrochlorothiazide
- Generic name
- Losartan potassium and Hydrochlorothiazide
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA202289
- Marketed since
- May 3, 2012
- Listing expires
- December 31, 2026
- Pharmacologic class
- Angiotensin 2 Receptor Blocker; Thiazide Diuretic
Active ingredients
- Losartan Potassium 100 mg/1
- Hydrochlorothiazide 12.5 mg/1
Uses, dosage, side effects and warnings for Losartan Potassium and Hydrochlorothiazide →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 33342-051-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-051-07) | Sep 10, 2012 |
| 33342-051-10 | 90 TABLET, FILM COATED in 1 BOTTLE (33342-051-10) | Sep 10, 2012 |
| 33342-051-12 | 10 BLISTER PACK in 1 CARTON (33342-051-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK | Sep 10, 2012 |
| 33342-051-44 | 1000 TABLET, FILM COATED in 1 BOTTLE (33342-051-44) | Sep 10, 2012 |
Recalls mentioning this NDC
- D-0498-2024 May 22, 2024 · Class II
Presence of foreign substance: plastic-like substance. - D-1164-2022 Jul 6, 2022 · Class II
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits - D-0835-2022 May 11, 2022 · Class II
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits - D-0837-2022 May 11, 2022 · Class II
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits - D-0836-2022 May 11, 2022 · Class II
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits - D-1460-2019 Jul 17, 2019 · Class II
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products. - D-1459-2019 Jul 17, 2019 · Class II
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products. - D-1461-2019 Jul 17, 2019 · Class II
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Other Losartan Potassium and Hydrochlorothiazide products
- 50090-7059 Losartan Potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-7237 Losartan Potassium 50 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-7199 Losartan Potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-1641 Losartan Potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-1745 Losartan Potassium 100 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-7058 Losartan Potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-6862 Losartan Potassium 50 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-2632 Losartan Potassium 50 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-5960 Losartan Potassium 100 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-5962 Losartan Potassium 50 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-6636 Losartan Potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-4447 Losartan Potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet, Film Coated · A-S Medication Solutions